MIT Center for Precision Cancer Medicine
CPCM Director Michael Yaffe elected to the American Surgical Association.
CPCM funded research from the Manalis lab results in technique to measure single-cell density for predicting whether immunotherapies will work in a patient.
A new Cell Systems paper from the White lab identified mechanisms that enable resistance to cancer therapies, offering new opportunities to intervene for better patient outcomes.
CPCM Member Angela Koehler appointed to lead MIT Health and Life Science Collaborative.
Spranger Lab and other CPCM members examine antigen expression patterns to improve immune checkpoint blockade therapies.